Recommendations For Gilead Sciences, Inc.
Gilead Sciences, Inc. (GILD.O) (Nasdaq)
sector: Healthcare ·
industry: Biotechnology ·
Consensus Recommendations
| Consensus Recommendation | Next Earnings (approx.) | Company Fiscal Year End Month |
Last Updated |
|---|---|---|---|
| Outperform | December | 25 Nov 2009 |
Analyst Recommendations and Revisions
| 1-5 Linear Scale | Current | 1 Month Ago |
2 Month Ago |
3 Month Ago |
|---|---|---|---|---|
| (1) BUY | 19 | 19 | 19 | 18 |
| (2) OUTPERFORM | 6 | 6 | 6 | 6 |
| (3) HOLD | 5 | 5 | 4 | 4 |
| (4) UNDERPERFORM | 0 | 0 | 0 | 0 |
| (5) SELL | 1 | 1 | 0 | 0 |
| No Opinion | 0 | 0 | 0 | 0 |
| Mean Rating | 1.65 | 1.65 | 1.48 | 1.50 |
Market Update
India
US
UK- Asia
- Most Actives
Commodities
| Commodity | Last | Pct Chg | Trade Date/Time |
|---|---|---|---|
| Oil | 76.93 | +0.61% | 11/25 13:03 IST |
| Gold | 1179.0 | +1.12% | 11/25 12:45 IST |
